"Our core semiconductor business grew again like-for-like in line with our target operating model. As promised, we are delivering a stronger second half in terms of top-line, bottom-line and cash flow ...

GSK funding has been allocated to new research programmes combining expertise and using cutting edge AI technology to accelerate AMR ...